Literature DB >> 12874315

Transfected Plasmodium knowlesi produces bioactive host gamma interferon: a new perspective for modulating immune responses to malaria parasites.

Hastings Ozwara1, Jan A M Langermans, Clemens H M Kocken, Annemarie van der Wel, Peter H van der Meide, Richard A W Vervenne, Jason M Mwenda, Alan W Thomas.   

Abstract

Transgenic pathogenic microorganisms expressing host cytokines such as gamma interferon (IFN-gamma) have been shown to manipulate host-pathogen interaction, leading to immunomodulation and enhanced protection. Expression of host cytokines in malaria parasites offers the opportunity to investigate the potential of an immunomodulatory approach by generating immunopotentiated parasites. Using the primate malaria parasite Plasmodium knowlesi, we explored the conditions for expressing host cytokines in malaria parasites. P. knowlesi parasites transfected with DNA constructs for expressing rhesus monkey (Macaca mulatta) IFN-gamma under the control of the heterologous P. berghei apical membrane antigen 1 promoter, produced bioactive IFN-gamma in a developmentally regulated manner. IFN-gamma expression had no marked effect on in vitro parasite development. Bioactivity of the parasite-produced IFN-gamma was shown through inhibition of virus cytopathic effect and confirmed by using M. mulatta peripheral blood cells in vitro. These data indicate for the first time that it is feasible to generate malaria parasites expressing bioactive host immunomodulatory cytokines. Furthermore, cytokine-expressing malaria parasites offer the opportunity to analyze cytokine-mediated modulation of malaria during the blood and liver stages of the infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874315      PMCID: PMC166026          DOI: 10.1128/IAI.71.8.4375-4381.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  Flow cytometric analysis on reactivity of human T lymphocyte-specific and cytokine-receptor-specific antibodies with peripheral blood mononuclear cells of chimpanzee (Pan troglodytes), rhesus macaque (Macaca mulatta), and squirrel monkey (Saimiri sciureus)

Authors:  H Ozwara; H Niphuis; L Buijs; M Jonker; J L Heeney; C S Bambra; A W Thomas; J A Langermans
Journal:  J Med Primatol       Date:  1997-06       Impact factor: 0.667

2.  Interleukin 12 induction of interferon gamma-dependent protection against malaria.

Authors:  M Sedegah; F Finkelman; S L Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

3.  Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.

Authors:  I A Clark; N H Hunt; G A Butcher; W B Cowden
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

4.  Structure and activity of glycosylated human interferon-gamma.

Authors:  T Arakawa; Y R Hsu; D Chang; N Stebbing; B Altrock
Journal:  J Interferon Res       Date:  1986-12

5.  Three-dimensional structure of recombinant human interferon-gamma.

Authors:  S E Ealick; W J Cook; S Vijay-Kumar; M Carson; T L Nagabhushan; P P Trotta; C E Bugg
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

6.  Precise timing of expression of a Plasmodium falciparum-derived transgene in Plasmodium berghei is a critical determinant of subsequent subcellular localization.

Authors:  C H Kocken; A M van der Wel; M A Dubbeld; D L Narum; F M van de Rijke; G J van Gemert; X van der Linde; L H Bannister; C Janse; A P Waters; A W Thomas
Journal:  J Biol Chem       Date:  1998-06-12       Impact factor: 5.157

Review 7.  T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages.

Authors:  E H Nardin; R S Nussenzweig
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

8.  IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism.

Authors:  S Mellouk; S J Green; C A Nacy; S L Hoffman
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

9.  Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients.

Authors:  R Kurzrock; M G Rosenblum; S A Sherwin; A Rios; M Talpaz; J R Quesada; J U Gutterman
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

10.  Circulating interferon in rabbits and monkeys after administration of human gamma interferon by different routes.

Authors:  K Cantell; S Hirvonen; L Pyhälä; A De Reus; H Schellekens
Journal:  J Gen Virol       Date:  1983-08       Impact factor: 3.891

View more
  2 in total

Review 1.  Investigating immune responses to parasites using transgenesis.

Authors:  Mebrahtu G Tedla; Alison L Every; Jean-Pierre Y Scheerlinck
Journal:  Parasit Vectors       Date:  2019-06-15       Impact factor: 3.876

2.  Validation of Plasmodium vivax centromere and promoter activities using Plasmodium yoelii.

Authors:  Kittisak Thawnashom; Miho Kaneko; Phonepadith Xangsayarath; Nattawat Chaiyawong; Kazuhide Yahata; Masahito Asada; John H Adams; Osamu Kaneko
Journal:  PLoS One       Date:  2019-12-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.